building a new paradigm in genetic security
Undisclosed DNA is at the beginning of our journey. In this section, you will find some corporate information and investor FAQs. Anyone interested in investing in Undisclosed DNA can contact us with any questions and expressions of interest.
We Welcome investor interest
Show us how far you think this technology can & should go
Undisclosed DNA is at the start of its journey, and we are always open always open to professional investors and venture capitalists.
Our unique technology is patented around the world covering an estimated 46% of the global population and all major economies.
What we offer is not just a “nice to have” bolt-on, but a DNA privacy and security which should be at the heart of all DNA databases now and in the future. Indeed, under current GDPR regulations, it should already be a requirement for all organisations hosting a DNA database of any kind to be licensing Undisclosed DNA.
Potential Market Size
It’s difficult to quantify the potential market size to which Undisclosed DNA’s technology could apply.
The size of the DNA sequencing marketplace is difficult to quantify. In 2024, Research and Markets valued the global market at US$14.8bn and predicted it would reach US$34.8 billion by 2029.
Meanwhile, Precedence Research has reached similar conclusions. They value the DNA sequencing marketplace at US$14.7bn in 2025, reaching US$25.6bn in 2029 and US$50.3bn by 2024.
Both predict significant market growth in the coming years. The potential market for Undisclosed DNA is therefore significant and given the legal requirement to use our technology, the potential revenue streams from licenses is substantial.
Trials
Undisclosed DNA has already run limited trials of our technology and it has proved extremely effective.
We are keen to run larger research trials to provide us with a deeper evidence base and we are talking with academic partners at the moment about this.
The Undisclosed DNA team are also exploring funding opportunities to support a commercial trial and have reached out to the Home Office to explore potential partnerships.
Mathematical Proof
While we are working to deliver comprehensive trial data to back up our technology, Undisclosed DNA’s unique and patented technology is a mathematical, algorithmic, and cryptographic solution and not a biological hypothesis.
All of the mathematical elements that underpin are technology are verifiable beyond reasonable doubt. The majority are widely accepted.
We can therefore offer investors mathematical proof that our technology works.
We invite all interested investors to contact us if they would like to see more of this.
Cost of Licenses
Undisclosed DNA is still finalising its costing strategy which will be based on a number of factors still to be finalised.
As noted above, given the market value and the legal requirement to use our technology, we are confident that whatever licence fee structure we decide upon, Undisclosed DNA’s technology has the potential to bring in significant and long-term revenue making us a great investment opportunity.